Cocrystal Pharma, Inc. (COCP) Misses Q3 EPS by 18c

Cocrystal Pharma, Inc. (NASDAQ: COCP) reported Q3 EPS of ($0.70), $0.18 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Cocrystal Pharma, Inc. (COCP) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Can global equities keep rising? UBS sees these factors driving upside
• UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'